AKEBIA THERAPEUTICS, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AKEBIA THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-09-30 was $7.49M.
- AKEBIA THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2018-12-31 was $13.39M.
- AKEBIA THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2025 was $7.49M.
- AKEBIA THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2018 was $13.39M.
- AKEBIA THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2014 was $244.73M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2025-12-31 | $7.49M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $7.49M 10-Q · filed 2025-11-10 | |
| 2018-12-31 | $13.39M 10-Q · filed 2019-05-09 | $13.39M 10-K · filed 2021-02-25 |
| 2014-12-31 | $244.73M 10-K · filed 2017-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |